KRYS logo

Krystal Biotech (KRYS) EBIT

annual EBIT:

$103.19M+$200.42M(+206.14%)
December 31, 2024

Summary

  • As of today (June 26, 2025), KRYS annual earnings before interest & taxes is $103.19 million, with the most recent change of +$200.42 million (+206.14%) on December 31, 2024.
  • During the last 3 years, KRYS annual EBIT has risen by +$171.27 million (+251.58%).
  • KRYS annual EBIT is now at all-time high.

Performance

KRYS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

quarterly EBIT:

$36.18M-$5.20M(-12.57%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS quarterly earnings before interest & taxes is $36.18 million, with the most recent change of -$5.20 million (-12.57%) on March 31, 2025.
  • Over the past year, KRYS quarterly EBIT has increased by +$30.36 million (+522.03%).
  • KRYS quarterly EBIT is now -12.57% below its all-time high of $41.38 million, reached on December 31, 2024.

Performance

KRYS quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

TTM EBIT:

$133.56M+$30.36M(+29.42%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS TTM earnings before interest & taxes is $133.56 million, with the most recent change of +$30.36 million (+29.42%) on March 31, 2025.
  • Over the past year, KRYS TTM EBIT has increased by +$188.64 million (+342.44%).
  • KRYS TTM EBIT is now at all-time high.

Performance

KRYS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

KRYS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+206.1%+522.0%+342.4%
3 y3 years+251.6%+243.4%+269.1%
5 y5 years+567.4%+777.4%+687.6%

KRYS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+185.9%-12.6%+195.1%at high+195.0%
5 y5-yearat high+185.9%-12.6%+195.1%at high+195.0%
alltimeall timeat high+185.9%-12.6%+195.1%at high+195.0%

KRYS EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$36.18M(-12.6%)
$133.56M(+29.4%)
Dec 2024
$103.19M(-206.1%)
$41.38M(+18.5%)
$103.19M(+58.9%)
Sep 2024
-
$34.93M(+65.8%)
$64.95M(+1512.9%)
Jun 2024
-
$21.07M(+262.2%)
$4.03M(-107.3%)
Mar 2024
-
$5.82M(+85.3%)
-$55.09M(-43.3%)
Dec 2023
-$97.23M(-19.1%)
$3.14M(-112.1%)
-$97.23M(-28.1%)
Sep 2023
-
-$25.99M(-31.7%)
-$135.13M(-3.9%)
Jun 2023
-
-$38.05M(+4.7%)
-$140.59M(+7.1%)
Mar 2023
-
-$36.32M(+4.5%)
-$131.30M(+9.2%)
Dec 2022
-$120.20M(+76.6%)
-$34.77M(+10.6%)
-$120.20M(+12.1%)
Sep 2022
-
-$31.45M(+9.4%)
-$107.23M(+17.4%)
Jun 2022
-
-$28.75M(+14.0%)
-$91.37M(+15.7%)
Mar 2022
-
-$25.22M(+15.7%)
-$78.98M(+16.0%)
Dec 2021
-$68.08M(+111.6%)
-$21.81M(+39.9%)
-$68.08M(+20.2%)
Sep 2021
-
-$15.59M(-4.7%)
-$56.66M(+11.8%)
Jun 2021
-
-$16.36M(+14.3%)
-$50.68M(+23.2%)
Mar 2021
-
-$14.32M(+37.9%)
-$41.15M(+27.9%)
DateAnnualQuarterlyTTM
Dec 2020
-$32.17M(+45.7%)
-$10.38M(+8.0%)
-$32.17M(+15.1%)
Sep 2020
-
-$9.61M(+40.6%)
-$27.94M(+18.0%)
Jun 2020
-
-$6.83M(+27.9%)
-$23.67M(+4.1%)
Mar 2020
-
-$5.34M(-13.2%)
-$22.73M(+2.9%)
Dec 2019
-$22.08M(+85.3%)
-$6.15M(+15.2%)
-$22.08M(+9.6%)
Sep 2019
-
-$5.34M(-9.3%)
-$20.14M(+13.3%)
Jun 2019
-
-$5.89M(+25.5%)
-$17.77M(+24.0%)
Mar 2019
-
-$4.69M(+11.3%)
-$14.33M(+20.3%)
Dec 2018
-$11.92M(+149.7%)
-$4.22M(+42.0%)
-$11.92M(+29.6%)
Sep 2018
-
-$2.97M(+21.4%)
-$9.20M(+10.6%)
Jun 2018
-
-$2.45M(+7.6%)
-$8.32M(+26.3%)
Mar 2018
-
-$2.28M(+52.0%)
-$6.58M(+38.0%)
Dec 2017
-$4.77M(+317.5%)
-$1.50M(-28.4%)
-$4.77M(+22.6%)
Sep 2017
-
-$2.09M(+192.7%)
-$3.89M(+83.5%)
Jun 2017
-
-$715.00K(+53.8%)
-$2.12M(+50.8%)
Mar 2017
-
-$465.00K(-25.0%)
-$1.41M(+49.4%)
Dec 2016
-$1.14M
-$620.00K(+92.5%)
-$942.00K(+192.5%)
Sep 2016
-
-$322.00K
-$322.00K

FAQ

  • What is Krystal Biotech annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Krystal Biotech?
  • What is Krystal Biotech annual EBIT year-on-year change?
  • What is Krystal Biotech quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Krystal Biotech?
  • What is Krystal Biotech quarterly EBIT year-on-year change?
  • What is Krystal Biotech TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Krystal Biotech?
  • What is Krystal Biotech TTM EBIT year-on-year change?

What is Krystal Biotech annual earnings before interest & taxes?

The current annual EBIT of KRYS is $103.19M

What is the all time high annual EBIT for Krystal Biotech?

Krystal Biotech all-time high annual earnings before interest & taxes is $103.19M

What is Krystal Biotech annual EBIT year-on-year change?

Over the past year, KRYS annual earnings before interest & taxes has changed by +$200.42M (+206.14%)

What is Krystal Biotech quarterly earnings before interest & taxes?

The current quarterly EBIT of KRYS is $36.18M

What is the all time high quarterly EBIT for Krystal Biotech?

Krystal Biotech all-time high quarterly earnings before interest & taxes is $41.38M

What is Krystal Biotech quarterly EBIT year-on-year change?

Over the past year, KRYS quarterly earnings before interest & taxes has changed by +$30.36M (+522.03%)

What is Krystal Biotech TTM earnings before interest & taxes?

The current TTM EBIT of KRYS is $133.56M

What is the all time high TTM EBIT for Krystal Biotech?

Krystal Biotech all-time high TTM earnings before interest & taxes is $133.56M

What is Krystal Biotech TTM EBIT year-on-year change?

Over the past year, KRYS TTM earnings before interest & taxes has changed by +$188.64M (+342.44%)
On this page